graph Evidence gap map comparisons
buparlisib based treatment
buparlisib plus fulvestrant
la/mBC - HR positive - L2 - all population 1   
Comparator:  vs fulvestrant; 
Risk of bias:  low;   some concerns;   high;  NA;